Nih
Nih funding pages collect matching grants, scholarships, benefits, fellowships, and other programs from the FindMyMoney.App directory. Use this page to compare current opportunities, then verify deadlines and eligibility on the official source before applying.
RFA-MH-27-205: Single Source: Accelerating Medicines Partnership Schizophrenia DPACC
NIH is inviting a single-source U24 cooperative agreement to Brigham and Women's Hospital for continuation of the AMP Schizophrenia Data Processing, Analysis, and Coordination Center, with applications due 9 June 2026 and one full award anticipated in FY2027.
RFA-NS-24-031: BRAIN Initiative Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18)
NIH’s BRAIN Initiative R18 NOFO supports proof-of-concept development of novel CNS recording and modulation technologies on a path toward human studies, with recurring 2026/2027 NIH submission windows.
RFA-NS-25-017: BRAIN Initiative—Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System
The NIH BRAIN Initiative FOA supports U01 projects that optimize existing neural recording and modulation technologies for use in behaving animals, with recurring application cycles through 2026 and 2027.
RFA-NS-25-021: BRAIN Initiative Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3)
NIH BRAIN Initiative cooperative agreement to accelerate translational development of recording and modulation devices for CNS disorders through milestone-driven UG3/UH3 funding and small clinical studies requiring FDA IDE pathways.
RFA-NS-25-022: BRAIN Initiative UH3 Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System
NIH's BRAIN Initiative UH3 opportunity funds first-in-human and early clinical studies of next-generation CNS recording or stimulation devices that are ready for milestone-based advancement toward translation and clinical adoption.
RFA-NS-25-023: HEAL Initiative Studies to Enable Analgesic Discovery (R61/R33, Clinical Trial Not Allowed)
NIH HEAL funds preclinical translational work to build stronger evidence for non-addictive analgesic discovery through a two-stage R61/R33 mechanism with no clinical trials and strict peer-review criteria.
RFA-NS-27-015: BRAIN Initiative Connectivity Across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed)
NIH’s BRAIN Initiative NOFO supports U01 cooperative agreement projects that build scalable technologies for brain-wide connectivity mapping, with an expected first-year commitment of about $10M and roughly 3–6 awards expected.
RFA-OD-25-008: Tobacco Regulatory Science Small Grant Program for New Investigators (R03 Clinical Trial Optional)
NIH and FDA’s interagency Tobacco Regulatory Science Program runs R03 small grants for early-career investigators developing pilot studies and methods that can directly inform FDA tobacco product regulation.
RFA-OD-25-010: Resource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed)
NIH/ORIP’s NIH-wide R24 opportunity funds development and improvement of broadly useful biomedical models, methods, and biological materials that can serve multiple NIH Institutes and Centers across multiple organ systems.
RFA-OD-25-012: Informatics, Coordination and Service Center for the Mutant Mouse Resource and Research Centers (U42)
A U42 cooperative agreement that funds the Mutant Mouse Resource and Research Center Consortium’s Informatics, Coordination and Service Center through a multi-component application with review cycles in 2026 and funding decisions in 2026/2027.